Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-014879
Filing Date
2021-06-21
Accepted
2021-06-21 17:06:08
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 630827
2 ex31-1.htm EX-31.1 11852
3 ex31-2.htm EX-31.2 11701
4 ex32-1.htm EX-32.1 7050
5 ex32-2.htm EX-32.2 6817
  Complete submission text file 0001493152-21-014879.txt   2563271

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aneb-20210331.xml EX-101.INS 270532
7 XBRL SCHEMA FILE aneb-20210331.xsd EX-101.SCH 27788
8 XBRL CALCULATION FILE aneb-20210331_cal.xml EX-101.CAL 39582
9 XBRL DEFINITION FILE aneb-20210331_def.xml EX-101.DEF 118943
10 XBRL LABEL FILE aneb-20210331_lab.xml EX-101.LAB 201810
11 XBRL PRESENTATION FILE aneb-20210331_pre.xml EX-101.PRE 188921
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40388 | Film No.: 211031662
SIC: 2834 Pharmaceutical Preparations